Pre-exposure prevention of viral entry (PREVENT)

Phase

Pre-clinical

Principal Investigator(s)

Jim Turpin

Objective

PREVENT (Pre-exposure prevention of viral entry) is an Integrated Preclinical/Clinical Program, with the overall goal to provide a comprehensive set of data to facilitate an informed decision on whether the antiviral lectin Griffithsin (GRFT) should progress in the topical microbicides pipeline.

Prevention Option(s)

Microbicides

Arms and Assigned Interventions

Products

GRFT

Official Code

PREVENT

Trial Sponsors

NIH, NIAID

January 2014

March 2019

Sites

University of Louisville

Louisville, Kentucky

United States of America

You are here

Pre-exposure prevention of viral entry (PREVENT)

University of Louisville